Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 84 publications
Preventing drug interactions with antiretrovirals in the aging HIV population: focusing on population pharmacokinetic modeling.
Journal: Expert opinion on drug metabolism & toxicology
Published: September 04, 2026
Progress toward longer-acting antiretroviral regimens for adult HIV treatment.
Journal: Expert review of clinical pharmacology
Published: August 26, 2026
Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.
Journal: Lancet (London, England)
Published: July 07, 2026
Lenacapavir treatment-emergent HIV-1 capsid resistance mutations are frequently associated with replication defects.
Journal: Science translational medicine
Published: January 07, 2026
SARS-CoV-2 resistance analyses from the Phase 3 OAKTREE study of obeldesivir in low-risk nonhospitalized participants with COVID-19.
Journal: Antiviral research
Published: October 14, 2025
New Strategies for a Vexing Problem: Injectables to the Rescue for People With Multidrug-Resistant HIV.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 12, 2025
Efficacy and safety of lenacapavir, teropavimab, and zinlirvimab: week-26 primary outcome results from a multicentre, open-label, randomised, active-controlled, phase 2 study.
Journal: The Lancet. Microbe
Published: September 12, 2025
Subcutaneous Lenacapavir in People With Multidrug-Resistant HIV-1: 156 Week Results of the CAPELLA Study.
Journal: Open forum infectious diseases
Published: August 05, 2025
Drug-drug interactions in patients living with HIV who undergo solid organ transplant.
Journal: Expert opinion on drug metabolism & toxicology
Published: August 04, 2025
Drug interactions in people with HIV treated with antivirals for other viral illnesses.
Journal: Expert opinion on drug metabolism & toxicology
Published: January 21, 2025
Efficacy and safety of obeldesivir in low-risk, non-hospitalised patients with COVID-19 (OAKTREE): a phase 3, randomised, double-blind, placebo-controlled study.
Journal: The Lancet. Infectious diseases
Published: December 20, 2024
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.
Journal: The New England journal of medicine
Published: November 27, 2024
Last Updated: 09/26/2026